Drug intelligence / Profile preview

SMOFlipid + Intralipid

Development stage
Unknown
Lead developer
Fresenius Kabi
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intravenous
01

Overview

SMOFlipid and Intralipid are both intravenous lipid emulsions used as sources of calories and essential fatty acids for patients requiring parenteral nutrition when oral or enteral nutrition is not possible or insufficient. SMOFlipid is a four-oil blend containing soybean oil (30%), medium-chain triglycerides (30%), olive oil (25%), and fish oil (15%). This combination provides a mix of omega-6, omega-9, and omega-3 fatty acids. In contrast, Intralipid typically contains only soybean oil as its primary fat source. Both products are administered intravenously to provide energy and essential fatty acids to support cellular function in patients unable to eat or absorb nutrients through the gastrointestinal tract. The mechanism of action involves supplying exogenous lipids for metabolic needs; additionally, intravenous lipid emulsions can act as "lipid sinks" in cases of toxicity from highly lipophilic drugs by absorbing these agents into the plasma compartment for redistribution and detoxification[1][2][4][5][6][8]. SMOFlipid has been associated with lower elevations in liver enzymes compared to 100% soybean oil emulsions like Intralipid[4]. Both products are used across all age groups including neonates.

Brand names
SMOFlipidIntralipid
Other names
lipid injectable emulsionintravenous fat emulsionlipid emulsion therapy

Beyond the preview

Go deeper on SMOFlipid + Intralipid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SMOFlipid + Intralipid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call